Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: the EPIPAN multicenter randomized controlled trial.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
31 05 2023
Historique:
received: 01 04 2023
accepted: 20 05 2023
medline: 2 6 2023
pubmed: 1 6 2023
entrez: 31 5 2023
Statut: epublish

Résumé

Findings from preclinical studies and one pilot clinical trial suggest potential benefits of epidural analgesia in acute pancreatitis. We aimed to assess the efficacy of thoracic epidural analgesia, in addition to usual care, in improving clinical outcomes of intensive care unit patients with acute pancreatitis. A multicenter, open-label, randomized, controlled trial including adult patients with a clinical diagnosis of acute pancreatitis upon admission to the intensive care unit. Participants were randomly assigned (1:1) to a strategy combining thoracic epidural analgesia and usual care (intervention group) or a strategy of usual care alone (control group). The primary outcome was the number of ventilator-free days from randomization until day 30. Between June 2014 and January 2019, 148 patients were enrolled, and 135 patients were included in the intention-to-treat analysis, with 65 patients randomly assigned to the intervention group and 70 to the control group. The number of ventilator-free days did not differ significantly between the intervention and control groups (median [interquartile range], 30 days [15-30] and 30 days [18-30], respectively; median absolute difference of - 0.0 days, 95% CI - 3.3 to 3.3; p = 0.59). Epidural analgesia was significantly associated with longer duration of invasive ventilation (median [interquartile range], 14 days [5-28] versus 6 days [2-13], p = 0.02). In a population of intensive care unit adults with acute pancreatitis and low requirement for intubation, this first multicenter randomized trial did not show the hypothesized benefit of epidural analgesia in addition to usual care. Safety of epidural analgesia in this setting requires further investigation. ClinicalTrials.gov registration number NCT02126332 , April 30, 2014.

Sections du résumé

BACKGROUND
Findings from preclinical studies and one pilot clinical trial suggest potential benefits of epidural analgesia in acute pancreatitis. We aimed to assess the efficacy of thoracic epidural analgesia, in addition to usual care, in improving clinical outcomes of intensive care unit patients with acute pancreatitis.
METHODS
A multicenter, open-label, randomized, controlled trial including adult patients with a clinical diagnosis of acute pancreatitis upon admission to the intensive care unit. Participants were randomly assigned (1:1) to a strategy combining thoracic epidural analgesia and usual care (intervention group) or a strategy of usual care alone (control group). The primary outcome was the number of ventilator-free days from randomization until day 30.
RESULTS
Between June 2014 and January 2019, 148 patients were enrolled, and 135 patients were included in the intention-to-treat analysis, with 65 patients randomly assigned to the intervention group and 70 to the control group. The number of ventilator-free days did not differ significantly between the intervention and control groups (median [interquartile range], 30 days [15-30] and 30 days [18-30], respectively; median absolute difference of - 0.0 days, 95% CI - 3.3 to 3.3; p = 0.59). Epidural analgesia was significantly associated with longer duration of invasive ventilation (median [interquartile range], 14 days [5-28] versus 6 days [2-13], p = 0.02).
CONCLUSIONS
In a population of intensive care unit adults with acute pancreatitis and low requirement for intubation, this first multicenter randomized trial did not show the hypothesized benefit of epidural analgesia in addition to usual care. Safety of epidural analgesia in this setting requires further investigation.
TRIAL REGISTRATION
ClinicalTrials.gov registration number NCT02126332 , April 30, 2014.

Identifiants

pubmed: 37259157
doi: 10.1186/s13054-023-04502-w
pii: 10.1186/s13054-023-04502-w
pmc: PMC10230742
doi:

Banques de données

ClinicalTrials.gov
['NCT02126332']

Types de publication

Equivalence Trial Journal Article Multicenter Study Pragmatic Clinical Trial Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

213

Subventions

Organisme : Société Française d'Anesthésie et de Réanimation
ID : Contrat de Recherche 2015
Organisme : Centre Hospitalier Universitaire de Clermont-Ferrand
ID : Appel d'Offres Interne 2014

Investigateurs

Elodie Caumon (E)
Julien Amat (J)
Dominique Morand (D)
Renaud Guérin (R)
Sébastien Perbet (S)
Benjamin Rieu (B)
Sophie Cayot (S)
Christian Chartier (C)
Camille Verlhac (C)
Christine Rolhion (C)
Justine Bourdier (J)
Bernard Cosserant (B)
Raiko Blondonnet (R)
Jean-Baptiste Joffredo (JB)
Thomas Costilles (T)
Damien Bouvier (D)
Lise Bernard (L)
Jean-Etienne Bazin (JE)
Laurence Roszyk (L)
Lydie Marie-Anne (L)
Raphaël Giraud (R)
Annick Puchois (A)
Cyril Boronad (C)
Marine Agullo (M)
Boris Jung (B)
Gérald Chanques (G)
Cécile Spirito (C)
Marion Monnin (M)
Albert Prades (A)
Moussa Cisse (M)
Anne Verchere (A)
Claudine Gniadek (C)
Fouad Belafia (F)
Daniel Verzilli (D)
Julie Carr (J)
Audrey De Jong (A)
Yannael Coisel (Y)
Jean-Marc Delay (JM)
Matthieu Conseil (M)
Marie Gonzalez (M)
Delphine Rosant (D)
Michel Prevot (M)
Bernard Claud (B)
François Brenas (F)
Lassane Zanre (L)
Philippe Bray (P)
Hélène Riera (H)
Emilie Gadea-Deschamps (E)
Pablo Massanet (P)
Caroline Boutin (C)
Saber Barbar (S)
David-Paul De Brauwere (DP)
Serge Lumbroso (S)
Amélie Maurin (A)
Sophie Lloret (S)
Laurent Muller (L)
Claire Roger (C)
Jean-Yves Lefrant (JY)
Loubna Elotmani (L)
Audrey Ayral (A)
Suzanne Renard (S)
Nadège Bouskila (N)
Gaspard Beaune (G)
Magali Farines-Raffoul (M)
Marie Lebouc (M)
Auguste Dargent (A)
Thomas Crozon (T)
Julien Clauzel (J)
Marinne Le Core (M)
Thomas Rimmelé (T)

Informations de copyright

© 2023. The Author(s).

Références

Acta Anaesthesiol Scand. 2006 Mar;50(3):265-82
pubmed: 16480459
N Engl J Med. 2019 May 23;380(21):1997-2008
pubmed: 31112383
Crit Care. 2013 Dec 05;17(6):R281
pubmed: 24314012
Ann Fr Anesth Reanim. 2011 Feb;30(2):105-12
pubmed: 21316909
Gastroenterology. 2012 Jun;142(7):1476-82; quiz e15-6
pubmed: 22425589
Anesthesiology. 2000 Sep;93(3):858-75
pubmed: 10969322
N Engl J Med. 2014 Nov 20;371(21):1983-93
pubmed: 25409371
Crit Care. 2016 May 04;20(1):116
pubmed: 27141977
Am J Respir Crit Care Med. 2019 Oct 1;200(7):828-836
pubmed: 31034248
BMC Anesthesiol. 2014 Apr 05;14:23
pubmed: 24708631
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Anaesth Crit Care Pain Med. 2015 Aug;34(4):217-23
pubmed: 26004880
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Anaesth Crit Care Pain Med. 2022 Jun;41(3):101060
pubmed: 35636304
JAMA. 2012 Mar 14;307(10):1053-61
pubmed: 22416101
Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416
pubmed: 23896955
Minerva Anestesiol. 2008 Oct;74(10):549-63
pubmed: 18854796
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Gut. 2020 Mar;69(3):604-605
pubmed: 31233394
N Engl J Med. 2016 Nov 17;375(20):1972-1981
pubmed: 27959604
World J Gastroenterol. 2015 Nov 21;21(43):12448-56
pubmed: 26604652
Anesthesiology. 2006 Aug;105(2):354-9
pubmed: 16871070
Ann Fr Anesth Reanim. 2008 Jul-Aug;27(7-8):541-51
pubmed: 18579339
Crit Care Med. 2018 Mar;46(3):e198-e205
pubmed: 29194144
Eur J Cardiothorac Surg. 2005 Sep;28(3):375-9
pubmed: 16054823
N Engl J Med. 2010 Apr 22;362(16):1491-502
pubmed: 20410514
Lancet. 2020 Sep 5;396(10252):726-734
pubmed: 32891214
Anesth Analg. 2007 Aug;105(2):453-9
pubmed: 17646505
World J Emerg Surg. 2019 Jun 13;14:27
pubmed: 31210778
BMJ Open. 2017 May 29;7(5):e015280
pubmed: 28554928
Crit Care. 2010;14(4):R139
pubmed: 20663207
Gastroenterology. 2018 Mar;154(4):1096-1101
pubmed: 29409760
Crit Care. 2018 Nov 22;22(1):321
pubmed: 30466472
Crit Care Med. 2001 Dec;29(12):2258-63
pubmed: 11801819
Anaesthesiol Reanim. 2002;27(1):16-22
pubmed: 11908096
Indian J Crit Care Med. 2019 Feb;23(2):89-94
pubmed: 31086453
Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15
pubmed: 24054878
Anesthesiology. 2013 Jan;118(1):134-42
pubmed: 23221864
World J Gastroenterol. 2006 Feb 14;12(6):915-20
pubmed: 16521220

Auteurs

Matthieu Jabaudon (M)

Department of Perioperative Medicine, CHU Clermont-Ferrand, 58 Rue Montalembert, 63000, Clermont-Ferrand, France. mjabaudon@chu-clermontferrand.fr.
iGReD, CNRS, INSERM, Université Clermont Auvergne, Clermont-Ferrand, France. mjabaudon@chu-clermontferrand.fr.

Alexandra Genevrier (A)

Department of Perioperative Medicine, CHU Clermont-Ferrand, 58 Rue Montalembert, 63000, Clermont-Ferrand, France.

Samir Jaber (S)

Saint Eloi Intensive Care Unit, CHU Montpellier, Montpellier, France.
PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France.

Olivier Windisch (O)

Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Division of Intensive Care, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.

Stéphanie Bulyez (S)

Division of Intensive Care, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.
Service de Recherche Clinique en Soins Critiques, Pôle Anesthésie Douleur Urgences Réanimation, CHU Nîmes, Université de Montpellier, Nîmes, France.

Pierre-François Laterre (PF)

Department of Critical Care Medicine, Saint Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium.

Etienne Escudier (E)

Department of Emergency Medicine and Intensive Care, Annecy Genevois General Hospital, Annecy, France.

Achille Sossou (A)

Department of Intensive Care Medicine, Emile-Roux General Hospital, Le Puy-en-Velay, France.

Philippe Guerci (P)

Department of Anesthesiology and Critical Care Medicine, CHU Nancy-Brabois, Nancy, France.
Institut Lorrain du Coeur Et Des Vaisseaux and INSERM U1116, Institut Lorrain du Coeur et des Vaisseaux, University of Lorraine, Nancy, France.

Pierre-Marie Bertrand (PM)

Department of Intensive Care Medicine, Cannes General Hospital, Cannes, France.

Pierre-Eric Danin (PE)

Department of Intensive Care Medicine, CHU Nice, Nice, France.
INSERM U1065, Team 8, C3M, CHU de Nice, Nice, France.

Martin Bonnassieux (M)

Department of Intensive Care Medicine, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

Leo Bühler (L)

Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Claudia Paula Heidegger (CP)

Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Division of Intensive Care, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.

Russell Chabanne (R)

Department of Perioperative Medicine, CHU Clermont-Ferrand, 58 Rue Montalembert, 63000, Clermont-Ferrand, France.

Thomas Godet (T)

Department of Perioperative Medicine, CHU Clermont-Ferrand, 58 Rue Montalembert, 63000, Clermont-Ferrand, France.

Laurence Roszyk (L)

iGReD, CNRS, INSERM, Université Clermont Auvergne, Clermont-Ferrand, France.
Department of Biochemistry and Molecular Genetics, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Vincent Sapin (V)

iGReD, CNRS, INSERM, Université Clermont Auvergne, Clermont-Ferrand, France.
Department of Biochemistry and Molecular Genetics, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Emmanuel Futier (E)

Department of Perioperative Medicine, CHU Clermont-Ferrand, 58 Rue Montalembert, 63000, Clermont-Ferrand, France.
iGReD, CNRS, INSERM, Université Clermont Auvergne, Clermont-Ferrand, France.

Bruno Pereira (B)

Biostatistics and Data Management Unit, Department of Clinical Research and Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Jean-Michel Constantin (JM)

Department of Anesthesiology and Critical Care, GRC 29, DMU DREAM, Pitié-Salpêtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH